Long-term use of naldemedine in the treatment of opioid-induced constipation in patients with chronic non-cancer pain: a randomized, double-blind, placebo-controlled phase 3 study

Chronic Pain

Tapering off long-term opioid therapy in chronic non-cancer pain patients: a randomized clinical trial

Eur J Pain.

Kurita GP, Højsted J, Sjøgren P

doi: 10.1002/ejp.1241.

Long-Term Safety and Efficacy of Subcutaneous Methylnaltrexone in Patients with Opioid-Induced Constipation and Chronic Noncancer Pain: A Phase 3, Open-Label Trial

Pain Med.

Webster LR, Michna E, Khan A, Israel RJ, Harper JR

doi: 10.1093/pm/pnx148.

Chronic Pain

All-cause mortality in patients with long-term opioid therapy compared with non-opioid analgesics for chronic non-cancer pain: a database study

BMC Med.

Häuser W, Schubert T, Vogelmann T, Maier C, Fitzcharles MA, Tölle T

doi: 10.1186/s12916-020-01644-4.

COMMENTED

Chronic Pain

The effects of long-term opioid treatment on the immune system in chronic non-cancer pain patients: A systematic review

★ 3 Recommended and commented by Dr Roland Schreiber, Faculty Member

Eur J Pain.

Diasso PDK, Birke H, Nielsen SD, Main KM, Højsted J, Sjøgren P, Kurita GP

doi: 10.1002/ejp.1506.

SPECIAL REPORT

HIV / AIDS

11^e Conférence de la Société internationale sur le SIDA (IAS) 2021

Back Pain

Tanezumab for chronic low back pain: a randomized, double-blind, placebo- and active-controlled, phase 3 study of efficacy and safety

Pain.

Markman JD, Bolash RB, McAlindon TE, Kivitz AJ, Pombo-Suarez M, Ohtori S, Roemer FW, Li DJ, Viktrup L, Bramson C, West CR, Verburg KM

doi: 10.1097/j.pain.0000000000001928.

COMMENTED

Back PainChronic Pain

Opioids for chronic low back pain. An updated systematic review and meta-analysis of efficacy, tolerability and safety in randomized placebo-controlled studies of at least four weeks double-blind duration

★ 3 Recommended and commented by Dr Roland Schreiber, Faculty Member

doi: 10.1002/ejp.1519.

Chronic Pain

Systematic review and meta-analysis on neuropsychological effects of long-term use of opioids in chronic non-cancer pain patients

Pain Pract.

Allegri N, Mennuni S, Rulli E, Vanacore N, Corli O, Floriani I, De Simone I, Allegri M, Govoni S, Vecchi T, Sandrini G1, Liccione D, Biagioli E

doi: 10.1111/papr.12741.

Back Pain

Oral methylnaltrexone does not negatively impact analgesia in patients with opioid-induced constipation and chronic noncancer pain

J Pain Res.

Webster LR, Israel RJ

doi: 10.2147/JPR.S160488.

Related content

Tapering off long-term opioid therapy in chronic non-cancer pain patients: a randomized clinical trial

Long-Term Safety and Efficacy of Subcutaneous Methylnaltrexone in Patients with Opioid-Induced Constipation and Chronic Noncancer Pain: A Phase 3, Open-Label Trial

All-cause mortality in patients with long-term opioid therapy compared with non-opioid analgesics for chronic non-cancer pain: a database study

The effects of long-term opioid treatment on the immune system in chronic non-cancer pain patients: A systematic review

11e Conférence de la Société internationale sur le SIDA (IAS) 2021

Tanezumab for chronic low back pain: a randomized, double-blind, placebo- and active-controlled, phase 3 study of efficacy and safety

Opioids for chronic low back pain. An updated systematic review and meta-analysis of efficacy, tolerability and safety in randomized placebo-controlled studies of at least four weeks double-blind duration

Systematic review and meta-analysis on neuropsychological effects of long-term use of opioids in chronic non-cancer pain patients

Oral methylnaltrexone does not negatively impact analgesia in patients with opioid-induced constipation and chronic noncancer pain

11^e Conférence de la Société internationale sur le SIDA (IAS) 2021